£150m investment planned for 2 Sisters poultry division
The UK’s leading poultry processor 2 Sisters Food Group has announced a new £150m (€207m) investment programme designed to “meet customer needs, drive efficiency and revolutionise the supply chain end-to-end”.
The aim, it says, is to create “world-class facilities with state of the art technology” over the next 3 to 4 years. “We are making a number of important investments with the aim of providing our customers with innovative products, better value and reduced waste,” said chief executive Ranjit Singh.
Campylobacter reduction
Further details are being withheld, though the £150m is additional to the £10m the company has already spent on reducing campylobacter, including blast surface chilling of carcasses and secondary scalding in the factories.
“With the further use of our new factory interventions, we anticipate an even greater removal of campylobacter, reducing its presence to significantly less than the industry target,” said a statement to investors.
You may also find interesting:
More cases of campylobacter in the UK
Despite a concerted effort by the poultry industry and the food safety authorities against campylobacter in chicken, the number of people infected by the disease is actually on the rise.
Declining sales
The announcement came as Boparan Holdings, 2 Sisters’ parent company, reported a year of declining sales and profit. In the 52 weeks to 1 August, total sales fell 8.2% to £3.14bn, while operating profit was down 34% to £58.8m (€81.5m). On a like-for-like bases, turnover was down 1.7% at £3.19bn (€4.42bn), with operating profit 38% lower at £60.4m (€83.7m). “The operating environment for our industry remains tough,” said Singh.
However, there were some signs of improvement, with a 17.5% increase in like-for-like operating profit to £22.8m (€31.6M) from Q3 to Q4. The dominant Protein division, which includes poultry and red meat, faced a number of challenges in the past year, the report adds.
You may also find interesting:
2 Sisters removes more antibiotics from poultry production
2 Sisters Food Group is removing all antibiotics considered “critically important to human health” by the World Health Organisation from its poultry production, to help counter the risk of antibiotics resistance in humans.
Growing poultry market share
“We have been working hard to mitigate the effects of the avian influenza outbreaks, negative consumer sentiment following FSA campylobacter reporting, and the impact of deflation throughout 2015.
“We are encouraged by the positive trends which continued in Q4, where our share of the UK poultry market grew by 4% versus Q3.” An IT systems glitch earlier in the year also cost the company £17.4m (€24.12m).
Source: Poultry World
Join 31,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the poultry sector, three times a week.
